Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

OssDsign® Spine Registry Study ("Propel")

NCT: NCT05329129 · RECRUITING

NCT IDNCT05329129
StatusRECRUITING
Start Date2022-03-23
Completion2027-04-01

Brief Summary

The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.

Frequently Asked Questions

What is OssDsign® Spine Registry Study ("Propel")?

OssDsign® Spine Registry Study ("Propel") is a clinical trial registered under NCT05329129. Current status: RECRUITING.

What is the status of NCT05329129?

The current status of NCT05329129 (OssDsign® Spine Registry Study ("Propel")) is: RECRUITING.

When did OssDsign® Spine Registry Study ("Propel") start?

OssDsign® Spine Registry Study ("Propel") started on 2022-03-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑